What happens to people who become HIV positive in prevention trials?
Microbicides: the quest for user-friendly formulations
Treatment and PrEP could be on a ‘collision course’, warns resistance expert
New WHO treatment criteria could prevent 90% of vertical transmission
Fat loss caused by some anti-HIV drugs persists in the long term
Collaborative TB and HIV services for drug users
